{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:07:54Z","timestamp":1791230874906,"version":"4.1.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T00:00:00Z","timestamp":1389139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0083449","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T21:45:41Z","timestamp":1389217541000},"page":"e83449","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":132,"title":["A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers"],"prefix":"10.1371","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct01188512","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Rigmor","family":"Thorstensson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birger","family":"Trollfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Al-Tawil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Jahnmatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaretha","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"T\u00f6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Wehlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Van Broekhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fons","family":"Bosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Debrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Mielcarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Locht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,8]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Vaccine-preventable diseases: monitoring system. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/immunization_monitoring\/diseases\/pertussis\/en\/index.html\" xlink:type=\"simple\">http:\/\/www.who.int\/immunization_monitoring\/diseases\/pertussis\/en\/index.html<\/ext-link>. Accessed 2013 Nov 14."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine","volume":"334","author":"L Gustafsson","year":"1996","journal-title":"N Engl J Med"},{"key":"ref3","first-page":"509","article-title":"Weekly epidemiological record","volume":"86","year":"2011"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/cid\/cis287","article-title":"Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American Outbreak","volume":"54","author":"MA Witt","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/jama.2012.6364","article-title":"Number and order of whole cell pertussis vaccines in infancy and disease protection","volume":"308","author":"SL Sheridan","year":"2012","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJMp1209051","article-title":"Epidemic pertussis in 2012\u2013 the resurgence of a vaccine-preventable disease","volume":"367","author":"JD Cherry","year":"2012","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1086\/589753","article-title":"Pathology and pathogenesis of fatal <italic>Bordetella pertussis<\/italic> infection in infants","volume":"47","author":"CD Paddock","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tim.2012.03.003","article-title":"Pertussis control: time for something new?","volume":"20","author":"TA Clark","year":"2012","journal-title":"Trends Microbiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1574-695X.2012.00988.x","article-title":"New pertussis vaccination approaches: en route to protect newborns?","volume":"66","author":"C Locht","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.vaccine.2011.12.047","article-title":"Vaccination of neonates: problems and issues","volume":"30","author":"DC Hodgins","year":"2012","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.4049\/jimmunol.170.3.1504","article-title":"<italic>Bordetella pertussis<\/italic> infection in 2-months-old infants promotes type 1 T cell responses","volume":"170","author":"F Mascart","year":"2003","journal-title":"J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1371\/journal.ppat.0020065","article-title":"Live attenuated <italic>B. pertussis<\/italic> as a single-dose nasal vaccine against whooping cough","volume":"2","author":"N Mielcarek","year":"2006","journal-title":"PLoS Pathog"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1128\/CVI.00082-09","article-title":"A live attenuated <italic>Bordetella pertussis<\/italic> candidate vaccine does not cause disseminated infection in gamma interferon receptor knockout mice","volume":"16","author":"CM Skerry","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.1016\/j.vaccine.2010.08.017","article-title":"Long-term immunity against pertussis induced by a single nasal administration of live attenuated <italic>B. pertussis<\/italic> BPZE1","volume":"28","author":"PF Feunou","year":"2010","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/CVI.00371-10","article-title":"A live, attenuated <italic>Bordetella pertussis<\/italic> vaccine provides long-term protection against virulent challenge in a murine model","volume":"18","author":"CM Skerry","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1016\/j.vaccine.2008.08.018","article-title":"Genetic stability of the live attenuated <italic>Bordetella pertussis<\/italic> vaccine candidate BPZE1","volume":"26","author":"PF Feunou","year":"2008","journal-title":"Vaccine"},{"key":"ref17","unstructured":"FDA. Available at <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/biologicsbloodvaccines\/guidancecomplianceregulatoryinformation\/guidances\/vaccines\/ucm074775.htm\" xlink:type=\"simple\">http:\/\/www.fda.gov\/biologicsbloodvaccines\/guidancecomplianceregulatoryinformation\/guidances\/vaccines\/ucm074775.htm<\/ext-link>. Accessed 2013 Nov 14."},{"key":"ref18","unstructured":"R Core Team (2012). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"BB Trunz","year":"2006","journal-title":"Lancet"},{"key":"ref20","first-page":"S24","article-title":"Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by <italic>Salmonella enterica<\/italic> Serovar Paratyphi B Clin Infect Dis","volume":"45","author":"MM Levine","year":"2007"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1128\/CVI.00322-09","article-title":"Dose response of attenuated <italic>Bordetella pertussis<\/italic> BPZE1-induced protection in mice","volume":"17","author":"N Mielcarek","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/CMR.18.2.326-382.2005","article-title":"Molecular Pathogenesis, Epidemiology, and clinical manifestations of respiratory infections due to <italic>Bordetella pertussis<\/italic> and other <italic>Bordetella<\/italic> subspecies","volume":"18","author":"S Mattoo","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1600-0463.2009.02521.x","article-title":"Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2\/3 antibodies after vaccination and infection","volume":"117","author":"HO Hallander","year":"2009","journal-title":"APMIS"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1128\/CVI.00469-09","article-title":"Antibody patterns to <italic>Bordetella pertussis<\/italic> in vaccinated (primed) and unvaccinated (unprimed young children with pertussis","volume":"17","author":"JD Cherry","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJM196201182660301","article-title":"Experimental whooping cough","volume":"266","author":"CC Huang","year":"1962","journal-title":"N Engl J Med"},{"key":"ref26","first-page":"257","article-title":"Demonstration of 1-year duration of immunity for attenuated <italic>Bordetella bronchiseptica<\/italic> vaccines in dogs","volume":"9","author":"C Lehar","year":"2008","journal-title":"Vet Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/317926","article-title":"Immunisation against influenza: comparison of various topical and parenteral regimens containing inactivated and\/or live attenuated vaccines in healthy adults","volume":"183","author":"WA Keitel","year":"2001","journal-title":"J Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/infdis\/168.5.1282","article-title":"Comparative trial of large-particle aerosol and nose drop administration of live attenuated influenza vaccines","volume":"168","author":"WC Gruber","year":"1993","journal-title":"J Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0264-410X(98)00226-6","article-title":"A search for serologic correlates of immunity to <italic>Bordetella pertussis<\/italic> cough illnesses","volume":"16","author":"JD Cherry","year":"1998","journal-title":"Vaccine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1016\/S0264-410X(03)00407-9","article-title":"Low levels of anti-pertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to <italic>Bordetella pertussis.<\/italic>","volume":"21","author":"J Storsaeter","year":"2003","journal-title":"Vaccine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0169-409X(01)00168-5","article-title":"Nasal vaccination using live bacterial vectors","volume":"51","author":"N Mielcarek","year":"2001","journal-title":"Adv Drug Deliv Rev"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0083449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:08:33Z","timestamp":1589040513000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0083449"}},"subtitle":[],"editor":[{"given":"Michiel","family":"van Boven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,8]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0083449","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,8]]}}}